BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9330621)

  • 1. Characterization of DNA adducts in Chinese hamster ovary cells treated with mutagenic doses of 1- and 3-nitrosobenzo[a]pyrene and the trans-7,8-diol-anti-9,10-epoxides of 1- and 3-nitrobenzo[a]pyrene.
    Zhan DJ; Chiu LH; Von Tungeln LS; Herreno-Saenz D; Cheng E; Evans FE; Heflich RH; Fu PP
    Mutat Res; 1997 Sep; 379(1):43-52. PubMed ID: 9330621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of mutation and comparison of mutation profiles in the hprt gene of Chinese hamster ovary cells treated with benzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, 1-nitrobenzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, and 3-nitrobenzo[a]pyrene trans-7,8- diol-anti-9,10-epoxide.
    Zhan DJ; Heflich RH; Fu PP
    Environ Mol Mutagen; 1996; 27(1):19-29. PubMed ID: 8625944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 3-nitrobenzo[a]pyrene bay-region trans-7,8-diol anti-9,10-epoxide and the corresponding N2-deoxyguanosine adduct.
    Fu PP; Wu YS; Von Tungeln LS; Lai JS; Chiarelli MP; Evans FE
    Chem Res Toxicol; 1993; 6(5):603-8. PubMed ID: 8292736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroreduction of 1- and 3-nitro-7,8,9,10-tetrahydrobenzo[a]pyrene and 1-nitrobenzo[a]pyrene resulting in formation of N2-deoxyguanosinyl adducts through long-range migration.
    Herreno-Saenz D; Evans FE; Fu PP
    Chem Res Toxicol; 1994; 7(6):806-14. PubMed ID: 7696536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of hprt mutations from Chinese hamster ovary cells treated with 1-, 3-, and 6-nitrosobenzo[a]pyrene.
    Zhan DJ; Chiu LH; Heflich RH; Fu PP
    Environ Mol Mutagen; 1998; 31(1):60-9. PubMed ID: 9464317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal activation of 1- and 3-nitrobenzo[a]pyrene to mutagens in Chinese hamster ovary cells.
    Thornton-Manning JR; Chou MW; Fu PP; Heflich RH
    Mutagenesis; 1988 May; 3(3):233-7. PubMed ID: 3045485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans- and cis-DNA adduct concentration in epidermis from mouse and rat skin treated ex vivo with benzo[a]pyrene diol epoxide and its corresponding chlorohydrin.
    Vock EH; Wolfe AR; Meehan T
    Mutat Res; 2001 Jul; 478(1-2):199-206. PubMed ID: 11406185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation and characterization of post-labeled DNA adducts of stereoisomers of benzo[a]pyrene-7,8-diol-9,10-epoxide by immobilized boronate chromatography and HPLC analysis.
    Lau HH; Baird WM
    Carcinogenesis; 1994 May; 15(5):907-15. PubMed ID: 8200094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-Postlabeling analysis of lipophilic DNA adducts resulting from interaction with (+/-)-3-hydroxy-trans-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo [a]pyrene.
    Arif JM; Shappell N; Sikka HC; Kumar S; Gupta RC
    Chem Biol Interact; 1999 Apr; 118(2):87-97. PubMed ID: 10359454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the rate of DNA adduct removal and the efficiency of mutagenesis for two benzo[a]pyrene diol epoxides in CHO cells.
    MacLeod MC; Daylong A; Adair G; Humphrey RM
    Mutat Res; 1991 Dec; 261(4):267-79. PubMed ID: 1722282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supercoiled DNA promotes formation of intercalated cis-N2-deoxyguanine adducts and base-stacked trans-N2-deoxyguanine adducts by (+)-7R,8S-dihydrodiol-9S,10R-epoxy-7,8,9,10-tetra- hydrobenzo[a]pyrene.
    Jiang G; Jankowiak R; Grubor N; Banasiewicz M; Small GJ; Skorvaga M; Van Houten B; States JC
    Chem Res Toxicol; 2004 Mar; 17(3):330-9. PubMed ID: 15025503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA adducts and carcinogenicity of nitro-polycyclic aromatic hydrocarbons.
    Fu PP; Herreno-Saenz D; Von Tungeln LS; Lay JO; Wu YS; Lai JS; Evans FE
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):177-83. PubMed ID: 7889844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low absolute mutagenic efficiency but high cytotoxicity of a non-bay region diol epoxide derived from benzo[a]pyrene.
    MacLeod MC; Adair G; Daylong A; Lew L; Humphrey RM
    Mutat Res; 1991 Dec; 261(4):281-93. PubMed ID: 1722283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of the adduct 6-(deoxyguanosin-N2-yl)-3-amino-benzo[a]pyrene from the mutagenic environmental contaminant 3-nitrobenzo[a]pyrene.
    Herreno-Saenz D; Evans FE; Abian J; Fu PP
    Carcinogenesis; 1993 May; 14(5):1065-7. PubMed ID: 8166885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the mutagenicity, metabolism, and DNA adduct formation of 5-nitrobenzo[b]naphtho[2,1-d]thiophene.
    King LC; Kohan MJ; Brooks L; Nelson GB; Ross JA; Allison J; Adams L; Desai D; Amin S; Padgett W; Lambert GR; Richard AM; Nesnow S
    Chem Res Toxicol; 2001 Jun; 14(6):661-71. PubMed ID: 11409936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity and liver tumor ras-protooncogene mutations in CD-1 mice treated neonatally with 1- and 3-nitrobenzo[a]pyrene and their trans-7,8-dihydrodiol and aminobenzo[a]pyrene metabolites.
    Von Tungeln LS; Xia Q; Bucci T; Heflich RH; Fu PP
    Cancer Lett; 1999 Apr; 137(2):137-43. PubMed ID: 10374834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts.
    Shou M; Harvey RG; Penning TM
    Carcinogenesis; 1993 Mar; 14(3):475-82. PubMed ID: 8384091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both replication bypass fidelity and repair efficiency influence the yield of mutations per target dose in intact mammalian cells induced by benzo[a]pyrene-diol-epoxide and dibenzo[a,l]pyrene-diol-epoxide.
    Lagerqvist A; Håkansson D; Prochazka G; Lundin C; Dreij K; Segerbäck D; Jernström B; Törnqvist M; Seidel A; Erixon K; Jenssen D
    DNA Repair (Amst); 2008 Aug; 7(8):1202-12. PubMed ID: 18479980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ratio of deoxyadenosine to deoxyguanosine adducts formed by (+)-(7R,8S,9S,10R)-7,8-dihydroxy-9,10-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in purified calf thymus DNA and DNA in V-79 cells is independent of dose.
    Wei SJ; Chang RL; Wong CQ; Cui XX; Dandamudi N; Lu YP; Merkler KA; Sayer JM; Conney AH; Jerina DM
    Int J Oncol; 1999 Mar; 14(3):509-13. PubMed ID: 10024684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.